Skip to main content

Diigo Home

Stakeholder Opinions: Restless Legs Syndrome - Novel drugs to prosper as lifec... - The Diigo Meta page

bharatbookseo.blogebay.com/...cle-management-strategies-fail - Cached

This link has been bookmarked by 1 people . It was first bookmarked on 13 Nov 2009, by Bharat Book.

  • 13 Nov 09
    bharatbook
    Bharat Book

    Restless legs syndrome (RLS) is a neurological condition, which affects 15.5 million medically significant sufferers across the seven major markets (7MM). Through Requip (ropinirole) and Mirapex’s (pramipexole) regulatory approvals in 200506, GlaxoSmithKline and Boehringer Ingelheim pioneered the on-label RLS market, which reached $588m in 2007 across the 7MM.

    Demand Market forecast growth Leaders Report Share Size Research Stakeholder Syndrome Strategies

Top Tags